Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Bugat

Showing results (71-80 of 149) with videos related to

Pageof 15
Sort By:
Presse Medicale (Paris, France : 1983)|February 11, 1995
[Interleukin-2 in a hemodialyzed patient with metastatic renal adenocarcinoma]E Suc, S Neuville, J L Lacombe, et al.
Bulletin Du Cancer|January 1, 1990
[Phase II trial as 2nd line chemotherapy with 5 fluorouracil and cisplatin (5FU-CDDP) for advanced breast cancer]P Fumoleau, P Bastit, D Horner, et al.
Thrombosis and Haemostasis|April 22, 1985
Platelet regeneration time after aspirin ingestion and platelet survival time after labelling with 51chromium or 111indium oxine--a comparative studyA Boneu, P Sié, R Bugat, et al.
European Journal of Clinical Pharmacology|January 1, 1997
Incidence and cost of adverse drug reactions in a French cancer instituteM Lapeyre-Mestre, J Gary, M Machelard-Roumagnac, et al.
International Journal of Radiation Oncology, Biology, Physics|February 1, 1991
Concomitant evaluation of efficiency, acute and delayed toxicities of combined treatment of radiation and CDDP on an in vivo modelA M Julia, P Canal, D Berg, et al.
Pathologie-Biologie|May 1, 1976
[Localization of HBsAg, immunoglobulins, fibrin and C3 in the liver by direct immunoflourescence]C Orfila, M Duffaut, M Mignon-Conte, et al.
Annales De Pathologie|January 1, 1985
[Merkel cell carcinoma of the skin. Anatomoclinical, ultrastructural and immunohistochemical study of 14 cases]J J Voigt, T Alsaati, B Gorguet, et al.
Bulletin Du Cancer|January 1, 1989
[Comparison of the pharmacokinetics of cisplatin administered by the intraperitoneal route in 2 dosages: 100 and 200 mg/m2]P Canal, E Chatelut, M De Forni, et al.
Bulletin Du Cancer|April 1, 1993
Anatomic changes in the abdominal cavity during intraperitoneal chemotherapy: prospective study using scintigraphic peritoneographyM de Forni, A Boneu, P Otal, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1989
Phase I/pharmacokinetic study of intraperitoneal teniposide (VM 26)P Canal, R Bugat, E Chatelut, et al.
Pageof 15

Showing results (71-80 of 149) with videos related to

Sort By:
Pageof 15
Presse Medicale (Paris, France : 1983)|February 11, 1995
[Interleukin-2 in a hemodialyzed patient with metastatic renal adenocarcinoma]E Suc, S Neuville, J L Lacombe, et al.
Bulletin Du Cancer|January 1, 1990
[Phase II trial as 2nd line chemotherapy with 5 fluorouracil and cisplatin (5FU-CDDP) for advanced breast cancer]P Fumoleau, P Bastit, D Horner, et al.
Thrombosis and Haemostasis|April 22, 1985
Platelet regeneration time after aspirin ingestion and platelet survival time after labelling with 51chromium or 111indium oxine--a comparative studyA Boneu, P Sié, R Bugat, et al.
European Journal of Clinical Pharmacology|January 1, 1997
Incidence and cost of adverse drug reactions in a French cancer instituteM Lapeyre-Mestre, J Gary, M Machelard-Roumagnac, et al.
International Journal of Radiation Oncology, Biology, Physics|February 1, 1991
Concomitant evaluation of efficiency, acute and delayed toxicities of combined treatment of radiation and CDDP on an in vivo modelA M Julia, P Canal, D Berg, et al.
Pathologie-Biologie|May 1, 1976
[Localization of HBsAg, immunoglobulins, fibrin and C3 in the liver by direct immunoflourescence]C Orfila, M Duffaut, M Mignon-Conte, et al.
Annales De Pathologie|January 1, 1985
[Merkel cell carcinoma of the skin. Anatomoclinical, ultrastructural and immunohistochemical study of 14 cases]J J Voigt, T Alsaati, B Gorguet, et al.
Bulletin Du Cancer|January 1, 1989
[Comparison of the pharmacokinetics of cisplatin administered by the intraperitoneal route in 2 dosages: 100 and 200 mg/m2]P Canal, E Chatelut, M De Forni, et al.
Bulletin Du Cancer|April 1, 1993
Anatomic changes in the abdominal cavity during intraperitoneal chemotherapy: prospective study using scintigraphic peritoneographyM de Forni, A Boneu, P Otal, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1989
Phase I/pharmacokinetic study of intraperitoneal teniposide (VM 26)P Canal, R Bugat, E Chatelut, et al.
Pageof 15